Rome, Italy

Anna Rita Pezzotti

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2003-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Anna Rita Pezzotti

Introduction

Anna Rita Pezzotti is an accomplished inventor based in Rome, Italy. She is recognized for her significant contributions in the fields of biotechnology and pharmaceuticals. With three patents to her name, Anna Rita demonstrates a noteworthy commitment to innovation in medical science.

Latest Patents

Anna Rita's latest patents reflect her dedication to advancing therapeutic methods. The first patent focuses on IFN beta protein analogs, providing a composition comprising an interferon-beta (IFN-beta) protein with at least 80% deamidation, along with methods for producing these proteins and their therapeutic applications. The second patent pertains to IL-6 antagonist peptides, which are selected from a peptide library using a two-hybrid system. These peptides possess the ability to bind to the intracellular domain of gp130 and include essential amino acids necessary for inhibiting IL-6 activity in various pathologies.

Career Highlights

Anna Rita has worked with several notable companies throughout her career. Among them are Applied Research Systems Ars Holding N.V. and Ares Trading S.A., where she has honed her skills in research and development. Her innovative approach continues to impact the biotechnology and pharmaceutical industries positively.

Collaborations

Throughout her journey, Anna Rita has collaborated with esteemed professionals in her field, including Ottaviano Serlupi-Crescenzi and Alessandro Bressan. These partnerships have enhanced her research capabilities and contributed to her success as an inventor.

Conclusion

Anna Rita Pezzotti stands out as an inspiring inventor committed to the advancement of medical science. Her innovative patents and collaborative efforts continue to push the boundaries of biotechnology, offering hopeful solutions for various health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…